相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polypharmacy definition and prevalence in heart failure: a systematic review
Janine Beezer et al.
HEART FAILURE REVIEWS (2022)
Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Yuzhong Wu et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2021)
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
Michael E. Nassif et al.
NATURE MEDICINE (2021)
Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT-HFpEF registry
Masami Nishino et al.
ESC HEART FAILURE (2021)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Polypharmacy in Older Adults Hospitalized for Heart Failure
Ozan Unlu et al.
CIRCULATION-HEART FAILURE (2020)
Clinical medication review type III of polypharmacy reduced unplanned hospitalizations in older adults: A meta-analysis of randomized clinical trials
Fumihiro Mizokami et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2019)
Polypharmacy and Incident Frailty in a Longitudinal Community-Based Cohort Study
Shahar Shmuel et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
The relationship between frailty and polypharmacy in older people: A systematic review
M. Gutierrez-Valencia et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia
Yirga Legesse Niriayo et al.
PLOS ONE (2018)
The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people
Adam Todd et al.
BMC GERIATRICS (2018)
Mode of Death in Heart Failure With Preserved Ejection Fraction
Muthiah Vaduganathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
What is polypharmacy? A systematic review of definitions
Nashwa Masnoon et al.
BMC GERIATRICS (2017)
Medication regimen complexity in ambulatory older adults with heart failure
Michael R. Cobretti et al.
CLINICAL INTERVENTIONS IN AGING (2017)
Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study
Barbara C. Wimmer et al.
ANNALS OF PHARMACOTHERAPY (2016)
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
Marco Proietti et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction
Parag Goyal et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Prognostic Impact of Loop Diuretics in Patients With Chronic Heart Failure - Effects of Addition of Renin-Angiotensin-Aldosterone System Inhibitors and β-Blockers
Masanobu Miura et al.
CIRCULATION JOURNAL (2016)
Left atrial changes in early stages of heart failure with preserved ejection fraction
Ibadete Bytyci et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Left atrial dimension is related to blood pressure variability in newly diagnosed untreated hypertensive patients
Franco Cipollini et al.
HYPERTENSION RESEARCH (2016)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction
Natalie A. Bello et al.
CIRCULATION-HEART FAILURE (2014)
Clinical consequences of polypharmacy in elderly
Robert L. Maher et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Insufficient Natriuretic Response to Continuous Intravenous Furosemide Is Associated With Poor Long-Term Outcomes in Acute Decompensated Heart Failure
Dhssraj Singh et al.
JOURNAL OF CARDIAC FAILURE (2014)
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
Andrew P. Ambrosy et al.
EUROPEAN HEART JOURNAL (2013)
How do patients with heart failure with preserved ejection fraction die?
Michelle M. Y. Chan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Adverse drug events in the outpatient setting: an 11-year national analysis
Florence T. Bourgeois et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Prescribing for older people
James C. Milton et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Pharmacological treatment in patients with heart failure:: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations
M Martínez-Sellés et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
分享论文
